Palisade Bio, Inc. Common Stock (PALI) is a publicly traded Healthcare sector company. As of September 3, 2026, PALI trades at $2.01 with a market cap of $341.57M and a P/E ratio of -6.62. PALI moved +0.50% today. Year to date, PALI is -20.40%; over the trailing twelve months it is +206.96%. Its 52-week range spans $0.53 to $2.86. Analyst consensus is strong buy with an average price target of $7.00. Rallies surfaces PALI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover PALI: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.00.
| Metric | Value |
|---|---|
| Price | $2.01 |
| Market Cap | $341.57M |
| P/E Ratio | -6.62 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.86 |
| 52-Week Low | $0.53 |
| Volume | 146.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-16.78M |
| Gross Margin | 0.00% |
5 analysts cover PALI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.00.